Error loading player: No playable sources found
CMC Strategy Forum Latin America 2021 - ENGLISH
Date
August 11, 2021
This product is not available for individual purchase, but it is available as part of the following products:
Session Speakers
Global Biotech Experts, LLC
AstraZeneca
Genentech, a Member of the Roche Group
Health Canada
Inmunova S.A.
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Session Chairs
Produtos Roche Químicos e Farmacêuticos S.A.
Merck Serona S.A.
ANMAT-National Administration of Medicines, Food and Medical Technology
DIGEMID-General Directorate of Medicines, Supplies and Drugs
Panel Members
COFEPRIS, Federal Commission for the Protection from Sanitary Risks
DIGEMID-General Directorate of Medicines, Supplies and Drugs
AstraZeneca
Related Products
Session II 2023 CMC Conversations in Latin America (English)
TUESDAY, 19 SEPTEMBER 2023 - SESSION II: Pathway to Optimizing Submission and Review of CMC Post-Approval Changes: Employing Scientific Risk-Based Principles, Reliance Pathways, Adoption of WHO Post-Approval Guidelines, and Collaborative Assessments
Session I 2023 CMC Conversations in Latin America (Spanish)
TUESDAY, 6 JUNE 2023 – SESSION I: Why optimize the submission and review of CMC post-approval changes? Global trends and challenges for Latin America
Session I 2023 CMC Conversations in Latin America (English)
TUESDAY, 6 JUNE 2023 – SESSION I: Why optimize the submission and review of CMC post-approval changes? Global trends and challenges for Latin America
Session 1 - Convergence of Regulatory Variation Category Assignment and Defined Health Authority Review Timelines through Risk-based Assessment of Post Approval Changes (Spanish)
SESSION CHAIRS: Cammilia Horta Gomes, _Produtos Roche Quimicos e Farmaceuticos S.A…
